STOCK TITAN

AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS

Amgen (NASDAQ:AMGN) will report first quarter 2026 financial results on Thursday, April 30, 2026, after the U.S. market close.

(Neutral)
(Very Positive)
Tags

Amgen (NASDAQ:AMGN) will report first quarter 2026 financial results on Thursday, April 30, 2026, after the U.S. market close. A conference call with management, including CEO Robert A. Bradway, will follow at 4:30 p.m. ET.

Live audio will be webcast on Amgen's investor site and archived for at least 90 days. Presentation times and webcast links are listed on Amgen's Investor Relations Events Calendar.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus Apr 27 session
-1.27% close to close Open Argus
Details

News Market Reaction – AMGN

In the Apr 27 session, AMGN declined 1.27%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets Amgen’s Q1 2026 results release for April 30, 2026, with a conference call at...
Analysis

This announcement sets Amgen’s Q1 2026 results release for April 30, 2026, with a conference call at 4:30 p.m. ET and webcast replay available for at least 90 days. Historically, similar webcast notices have been routine markers in a steady cadence of quarterly earnings, while the more market-moving information has come with the actual results. Upcoming metrics on revenue, EPS and guidance will be key for context versus prior 2025 performance.

Key Figures

Results date: April 30, 2026 Call time: 4:30 p.m. ET Webcast archive period: 90 days
Results date
April 30, 2026
Q1 2026 financial results reporting date
Call time
4:30 p.m. ET
Start time for Q1 2026 earnings conference call
Webcast archive period
90 days
Minimum replay availability for earnings webcast

Previous Earnings Reports

5 past events · Latest: Feb 03
Same Type 5 events
  1. Feb 03

    Earnings report

    24h Move
    +8.2%

    Strong FY 2025 revenue, EPS growth and cash flow with mixed product trends.

  2. Jan 28

    Earnings webcast

    24h Move
    +0.2%

    Announcement of Q4 2025 and full-year 2025 results webcast and timing.

  3. Nov 04

    Earnings report

    24h Move
    +7.8%

    Q3 2025 revenue and EPS growth with improved GAAP margin and debt reduction.

  4. Oct 29

    Earnings webcast

    24h Move
    +0.1%

    Scheduling of Q3 2025 results release and investor webcast details.

  5. Aug 05

    Earnings report

    24h Move
    -5.1%

    Q2 2025 revenue and EPS growth with strength in key growth products.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

THOUSAND OAKS, Calif., April 24, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2026 financial results on Thursday, April 30, 2026, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.

More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions.

Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads.

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2026-first-quarter-financial-results-302753310.html

SOURCE Amgen

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Amgen (AMGN) report its Q1 2026 earnings and at what time is the webcast?

Amgen will report Q1 2026 results on April 30, 2026, after market close, with a webcast at 4:30 p.m. ET. According to the company, the conference call follows the release and will be available via live audio webcast on Amgen's investor website.

Who will participate in the Amgen (AMGN) Q1 2026 conference call?

Amgen's CEO Robert A. Bradway and other senior management will participate on the call. According to the company, the management team will present results and answer investor questions during the webcasted conference call.

Where can investors find the Amgen (AMGN) Q1 2026 webcast and replay?

The live webcast and archived replay will be available on Amgen's investor website under Investors. According to the company, the webcast will be archived and accessible for at least 90 days after the event.

Will the Amgen (AMGN) Q1 2026 webcast be open to media and the general public?

Yes, the live audio webcast will be open to news media, investors and the general public. According to the company, the broadcast will be simultaneously available over the internet on Amgen's investor site.

Keep reading